Evidence map›Paper›PMID 38426622›Full record

ReviewCancer medicine2024

Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer.

Alexis K Elfstrum, Aditi S Bapat, Kathryn L Schwertfeger

Open access · goldAbstract readReview
In one paragraph

Review in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Breast Cancer: Extracellular Matrix and Microbiome Interactions.International journal of molecular sciences · 2024
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alexis K ElfstrumMicrobiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, Minnesota, USA.
Aditi S BapatMolecular Pharmacology and Therapeutics Graduate Program, University of Minnesota, Minneapolis, Minnesota, USA.
Kathryn L SchwertfegerDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-9755-7774
University of Minnesota · US

Funding

Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and ProgressionR01CA215052 · NCI · UNIVERSITY OF MINNESOTA · PI Kathryn L Schwertfeger · 2017 to 2026
$3.6M
Functions of ductal- and stromal-associated macrophages in the mammary glandR01HD106929 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI Heather L Machado, Kathryn L Schwertfeger · 2022 to 2026
$2.4M
Defining the contributions of Lyve-1 expressing macrophages to breast cancer growth and progressionR01CA265004 · NCI · UNIVERSITY OF MINNESOTA · PI Kathryn L Schwertfeger · 2022 to 2026
$2.0M
Regulation of tissue resident macrophages during mammary gland developmentR01HD095858 · NICHD · UNIVERSITY OF MINNESOTA · PI SCHWERTFEGER, KATHRYN L · 2018 to 2022
$1.9M
NCI NIH HHS R01 CA215052NCI NIH HHS R01CA215052NCI NIH HHS R01 CA265004NCI NIH HHS R01CA265004NICHD NIH HHS R01 HD095858NICHD NIH HHS R01 HD106929
6 · The paper itself

Abstract

introductionMacrophages are innate immune cells that are associated with extensive phenotypic and functional plasticity and contribute to normal development, tissue homeostasis, and diseases such as cancer. In this review, we discuss the heterogeneity of tissue resident macrophages in the normal mammary gland and tumor-associated macrophages in breast cancer. Tissue resident macrophages are required for mammary gland development, where they have been implicated in promoting extracellular matrix remodeling, apoptotic clearance, and cellular crosstalk. In the context of cancer, tumor-associated macrophages are key drivers of growth and metastasis via their ability to promote matrix remodeling, angiogenesis, lymphangiogenesis, and immunosuppression.

methodWe identified and summarized studies in Pubmed that describe the phenotypic and functional heterogeneity of macrophages and the implications of targeting individual subsets, specifically in the context of mammary gland development and breast cancer. We also identified and summarized recent studies using single-cell RNA sequencing to identify and describe macrophage subsets in human breast cancer samples.

resultsAdvances in single-cell RNA sequencing technologies have yielded nuances in macrophage heterogeneity, with numerous macrophage subsets identified in both the normal mammary gland and breast cancer tissue. Macrophage subsets contribute to mammary gland development and breast cancer progression in differing ways, and emerging studies highlight a role for spatial localization in modulating their phenotype and function.

conclusionUnderstanding macrophage heterogeneity and the unique functions of each subset in both normal mammary gland development and breast cancer progression may lead to more promising targets for the treatment of breast cancer.

Indexed as

Breast NeoplasmsMammary Glands, HumanAnimalsBreastFemaleHumansMacrophagesMammary Glands, Animalbreast cancerLYVE-1macrophagemammary glandTREM2

Identifiers

PMID38426622
PMCPMC10905685
OpenAlexW4392391471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.